MNPR Sale Disclosure
Anderson Raymond · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$105.2K
Anderson Raymond Director
MNPR
Monopar Therapeutics
MNPR
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
MNPR daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,502 shares @ $70.04
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001437749-26-035040
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$309K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monopar Therapeutics MNPR | Sale | Nov 2, 2026 | $40.24K |
| Monopar Therapeutics MNPR | Sale | Nov 2, 2026 | $55.57K |
| Monopar Therapeutics MNPR | Exercise | Nov 2, 2026 | $52.2K |
| Monopar Therapeutics MNPR | Sale | Nov 2, 2026 | $13.74K |
| Monopar Therapeutics MNPR | Exercise | Nov 2, 2026 | $0 |
| Monopar Therapeutics MNPR Current | Sale | Nov 2, 2026 | $105.2K |
| Monopar Therapeutics MNPR | Exercise | Nov 2, 2026 | $0 |
| Monopar Therapeutics MNPR | Exercise | Nov 2, 2026 | $42.06K |